Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Multiple New Multi-Commodity Targets next post Excellent Gold Intersections Verified at Kiimala Project You may also like Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025 Nickel Price Update: Q2 2025 in Review July 29, 2025 EL2780 Award – New Targets from Airborne MT May 15, 2025 US Policy Momentum, Clinical Progress Fueling Psychedelics Market... May 9, 2025 Editor’s Picks: ECB Issues Gold Warning, Uranium Stocks... May 24, 2025 Brunswick Exploration June 19, 2025 Peter Krauth: Silver Price Running, Stocks Exploding —... June 12, 2025 Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due... April 26, 2025 Triumph Gold Updates Shareholders on Operations, Engages Market... May 10, 2025 Clarification to Offtake & Distribution Agreement May 1, 2025